These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8300122)

  • 1. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor antibodies for immunotherapy of ovarian carcinomas.
    Wagner U
    Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
    Bast RC; Knapp RC
    Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
    Wagner UA; Oehr PF; Reinsberg J; Schmidt SC; Schlebusch HW; Schultes B; Werner A; Prietl G; Krebs D
    Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent immunologic advances affecting the management of ovarian cancer.
    Freedman RS
    Clin Obstet Gynecol; 1985 Dec; 28(4):853-71. PubMed ID: 4075635
    [No Abstract]   [Full Text] [Related]  

  • 6. Preface.
    Tainsky MA; Morris RT
    Cancer Metastasis Rev; 2015 Mar; 34(1):3. PubMed ID: 25648358
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiotypic cascades after MAb OC125 application.
    Reinsberg J
    Hybridoma; 1993 Oct; 12(5):577-82. PubMed ID: 8300133
    [No Abstract]   [Full Text] [Related]  

  • 8. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer.
    Schlebusch H; Wagner U; Grünn U; Schultes B
    Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu.
    Valone FH; Kaufman PA; Guyre PM; Lewis LD; Memoli V; Ernstoff MS; Wells W; Barth R; Deo Y; Fisher J
    J Hematother; 1995 Oct; 4(5):471-5. PubMed ID: 8581387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
    Wang J; Qian H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with CAMPATH-I and other monoclonal antibodies.
    Hale G; Phillips JM
    Biochem Soc Trans; 1995 Nov; 23(4):1057-63. PubMed ID: 8654681
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotherapy of ovarian cancer.
    Lidor Y; Bast RC
    Nat Immun Cell Growth Regul; 1988; 7(4):193-215. PubMed ID: 3070370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
    Zent CS; Kay NE
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):107-13. PubMed ID: 16163170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
    Wagner U; Reinsberg J; Krebs D
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TAG-72 antibody B72.3--immunological and clinical effects in ovarian carcinoma.
    Schmolling J; Reinsberg J; Wagner U; Krebs D
    Hybridoma; 1997 Feb; 16(1):53-8. PubMed ID: 9085129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
    Knogler K; Grünberg J; Zimmermann K; Cohrs S; Honer M; Ametamey S; Altevogt P; Fogel M; Schubiger PA; Novak-Hofer I
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):603-11. PubMed ID: 17255283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.